Acrotech Biopharma Patents – Insights & Stats (Updated 2023)

Acrotech Biopharma has a total of 32 patents globally, out of which 26 have been granted. Of these 32 patents, more than 87% patents are active. The United States of America is where Acrotech Biopharma has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Acrotech Biopharma.

Acrotech Biopharma was founded in 2018. The Company was founded as a global platform for the commercialization of novel patented pharmaceuticals. The company introduces cutting-edge scientific products to fill gaps in the market for benefitting patients and other parties involved in the healthcare. The company intends to be a patient-focused, research-based firm that strives to make medicines available to people who require them.

Do read about some of the most popular patents of Acrotech Biopharma which have been covered by us in this article and also you can find Acrotech Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Acrotech Biopharma patent portfolio.

How many patents does Acrotech Biopharma have?

Acrotech Biopharma has a total of 32 patents globally. These patents belong to 11 unique patent families. Out of 32 patents, 28 patents are active.

How Many Patents did Acrotech Biopharma File Every Year?

Acrotech Biopharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAcrotech Biopharma Applications FiledAcrotech Biopharma Patents Granted

How many Acrotech Biopharma patents are Alive/Dead?

Worldwide Patents

Acrotech Biopharma Patent Portfolio

How Many Patents did Acrotech Biopharma File in Different Countries?

Acrotech Biopharma Worldwide Patent Filing

Countries in which Acrotech Biopharma Filed Patents

United States Of America10
Former Yugoslav Republic of Macedonia1
South Africa1

Where are Research Centers of Acrotech Biopharma Patents Located?

R&D Centers of Acrotech Biopharma

Best Acrotech Biopharma Patent

US6723338B1 is the most popular patent in the Acrotech Biopharma portfolio. It has received 85 citations so far from companies like Inex Pharmaceuticals Corporation, Transave and Neopharm.

What Percentage of Acrotech Biopharma US Patent Applications Were Granted?

Acrotech Biopharma (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.

Below are the key stats of Acrotech Biopharma patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Acrotech Biopharma?

Law FirmTotal ApplicationsSuccess Rate
Lerner David Littenberg1100%

List of Acrotech Biopharma Patents

Acrotech Biopharma PatentsTitle
US11559486B2Ready-To-Use Formulation For Vincristine Sulfate Liposome Injection
US11541012B1Compositions Comprising Disodium Levofolinate
US11266614B2Oral Formulations Of Belinostat
US11020363B2Injectable Nitrogen Mustard Compositions Comprising A Cyclodextrin Derivative And Methods Of Making And Using The Same
US9801874B2Method For The Preparation Of Liposome Encapsulated Vincristine For Therapeutic Use
US9713616B2Pharmaceutical Compositions Comprising L-Leucovorin
EP3644970B8New Oral Formulations Of Belinostat
MK12426BNew Oral Formulation Of Belinostat
SKE39736T3New Oral Formulations Of Belinostat
MTP41034BNew Oral Formulations Of Belinostat
SI3644970T1New Oral Formulations Of Belinostat
HRP20220309T1New Oral Formulations Of Belinostat
ES2909583T3New Oral Formulations Of Belinostat
RS63046B1New Oral Formulations Of Belinostat
PL3644970T3New Oral Formulations Of Belinostat
DK3644970T3New Oral Formulations Of Belinostat
DE602018030579T2New Oral Formulations Of Belinostat
IT202200028577T2New Oral Formulations Of Belinostat
NO3644970B1New Oral Formulations Of Belinostat
HUE057999T2New Oral Formulations Of Belinostat
PT3644970TNew Oral Formulations Of Belinostat
CL67518BBelinostat Solid Amorphous Dispersion; Preparation Process; Pharmaceutical Composition And Use To Treat Cancer.
IN438482BNew Oral Formulations Of Belinostat
ZA201908532BNew Oral Formulations Of Belinostat
CA3067723A1New Oral Formulations Of Belinostat
AU2018294561A1New Oral Formulations Of Belinostat
IL271658ANew Oral Formulations Of Belinostat
BR112019028088A8Belinostate Amorphous Solid Dispersion, Preparation Process Of Belinostate Amorphous Solid Dispersion And Pharmaceutical Composition
US7887836B2Compositions And Methods For Treating Lymphoma
US7247316B2Compositions And Methods For Treating Lymphoma
US7244450B2Compositions And Methods For Treating Lymphoma
US6723338B1Compositions And Methods For Treating Lymphoma

What are Acrotech Biopharma key innovation segments?

What Technologies are Covered by Acrotech Biopharma?

The chart below distributes patents filed by Acrotech Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Acrotech Biopharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Acrotech Biopharma search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Acrotech Biopharma?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.